PMID- 8546705 OWN - NLM STAT- MEDLINE DCOM- 19960214 LR - 20190501 IS - 0264-6021 (Print) IS - 1470-8728 (Electronic) IS - 0264-6021 (Linking) VI - 313 ( Pt 1) IP - Pt 1 DP - 1996 Jan 1 TI - Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide. PG - 343-51 AB - The formation of a non-covalent complex between mature transforming growth factor beta 1 (TGF-beta 1) and its pro region, the beta 1-latency-associated peptide (beta 1-LAP), is important in regulating the activity of this multipotent growth factor. We have overexpressed simian beta 1-LAP in Chinese hamster ovary (CHO) cells to produce a cell line which secretes beta 1-LAP into the culture medium at > 1 mg/l, thus enabling structural studies of complex formation between beta 1-LAP and TGF-beta 1. The simian beta 1-LAP expressed in CHO cells reversed the growth inhibitory effect of exogenous TGF-beta 1 on Mv1Lu (mink lung epithelial) cells and was able to form a cross-linked complex with 125I-TGF-beta 1. Simian beta 1-LAP was purified to homogeneity by a combination of ammonium sulphate precipitation, gel filtration, dye ligand chromatography and anion-exchange chromatography, with a yield of 15%. The purified protein had an apparent molecular mass of 114 kDa as determined by SDS/PAGE, which is greater than that determined for the transient expression of simian beta 1-LAP in COS-1 and for the simian precursor of TGF-beta 1 (pro-TGF-beta 1) in CHO cells, this major difference being due to more extensive glycosylation of beta 1-LAP expressed by this CHO clone. Far-UV CD spectroscopy of simian beta 1-LAP indicates a mostly beta-sheet structure, with extensive structural rearrangements occurring upon formation of the latent complex between TGF-beta 1 and beta 1-LAP. FAU - McMahon, G A AU - McMahon GA AD - Biochemistry and Molecular Biology, Medical College of Ohio, Toledo 43699-0008, USA. FAU - Dignam, J D AU - Dignam JD FAU - Gentry, L E AU - Gentry LE LA - eng GR - CA60848/CA/NCI NIH HHS/United States GR - DE09669/DE/NIDCR NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (Carbohydrates) RN - 0 (DNA, Complementary) RN - 0 (Mannosephosphates) RN - 0 (Peptide Fragments) RN - 0 (Protein Precursors) RN - 0 (Proteins) RN - 0 (Transforming Growth Factor beta) RN - 0 (Transforming Growth Factor beta1) RN - 3672-15-9 (mannose-6-phosphate) RN - EC 1.5.1.3 (Tetrahydrofolate Dehydrogenase) SB - IM MH - Animals MH - CHO Cells/metabolism MH - Carbohydrates/analysis MH - Cell Division/drug effects MH - Cell Line MH - Chemical Precipitation MH - Chromatography, Ion Exchange MH - Circular Dichroism MH - Cricetinae MH - DNA, Complementary/genetics MH - Gene Amplification MH - Lung/cytology/drug effects MH - Mannosephosphates/analysis MH - Mink MH - *Peptide Fragments MH - *Protein Precursors MH - Protein Structure, Secondary MH - Proteins/*isolation & purification/*metabolism/physiology MH - Tetrahydrofolate Dehydrogenase/genetics MH - Transforming Growth Factor beta/chemistry/*metabolism/pharmacology MH - Transforming Growth Factor beta1 PMC - PMC1216904 EDAT- 1996/01/01 00:00 MHDA- 1996/01/01 00:01 PMCR- 1996/07/01 CRDT- 1996/01/01 00:00 PHST- 1996/01/01 00:00 [pubmed] PHST- 1996/01/01 00:01 [medline] PHST- 1996/01/01 00:00 [entrez] PHST- 1996/07/01 00:00 [pmc-release] AID - 10.1042/bj3130343 [doi] PST - ppublish SO - Biochem J. 1996 Jan 1;313 ( Pt 1)(Pt 1):343-51. doi: 10.1042/bj3130343.